Department of Urology, Universitätsmedizin Berlin, Charité Campus Benjamin Franklin, Germany.
BJU Int. 2011 Jun;107(12):1956-62. doi: 10.1111/j.1464-410X.2010.09795.x. Epub 2010 Nov 2.
• To investigate a single institution experience with radical retropubic prostatectomy (RRP), laparoscopic radical prostatectomy (LRP) and robot-assisted radical prostatectomy (RARP) with respect to pathological and biochemical outcomes.
• A group of 522 consecutive patients who underwent RARP between 2003 and 2008 were matched by propensity scoring on the basis of patient age, race, preoperative prostate-specific antigen (PSA), biopsy Gleason score and clinical stage with an equal number of patients who underwent LRP and RRP at our institution. • Pathological and biochemical outcomes of the three cohorts were examined.
• Overall positive surgical margin rates were lower among patients who underwent RRP (14.4%) and LRP (13.0%) compared to patients who underwent RARP (19.5%) (P= 0.010). There were no statistically significant differences in positive margin rates between the three surgical techniques for pT2 disease (P= 0.264). • In multivariate logistic regression analysis, surgical technique (P= 0.016), biopsy Gleason score (P < 0.001) and preoperative PSA (P < 0.001) were predictors of positive surgical margins. • Kaplan-Meier analysis did not show any statistically significant differences with respect to biochemical recurrence for the three surgical groups.
• RRP, LRP and RARP represent effective surgical approaches for the treatment for clinically localized prostate cancer. A higher overall positive SM rate was observed for the RARP group compared to RRP and LRP; however, there was no difference with respect to biochemical recurrence-free survival between groups. • Further prospective studies are warranted to determine whether any particular technique is superior with regard to long-term clinical outcomes.
我们对 2003 年至 2008 年间接受 RARP 的 522 例连续患者进行了分组,通过患者年龄、种族、术前前列腺特异性抗原(PSA)、活检 Gleason 评分和临床分期等因素进行倾向评分匹配,与同期在我院接受 LRP 和 RARP 的患者进行匹配。
比较了三组患者的病理和生化结果。
RRP 和 LRP 组的总阳性切缘率(14.4%和 13.0%)低于 RARP 组(19.5%)(P=0.010)。在 pT2 疾病中,三种手术技术的阳性切缘率没有统计学差异(P=0.264)。
多变量逻辑回归分析表明,手术技术(P=0.016)、活检 Gleason 评分(P<0.001)和术前 PSA(P<0.001)是阳性切缘的预测因素。
Kaplan-Meier 分析显示,三组患者在生化复发方面没有统计学差异。
RRP、LRP 和 RARP 是治疗局限性前列腺癌的有效手术方法。与 RRP 和 LRP 相比,RRP 组总的阳性切缘率更高;然而,三组患者在生化无复发生存方面没有差异。
需要进一步的前瞻性研究来确定哪种技术在长期临床结果方面具有优势。